- Home
- DRIO
DRIO
DarioHealth Corp.
as 05-09-2025 4:00pm EST
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Upcoming Earnings Alert:
Get ready for potential market movements as DarioHealth Corp. DRIO prepares to release earnings report on 14 May 2025.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 23.9M | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 285.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.50 - $1.93 | Next Earning Date: | 05-14-2025 |
| Revenue: | $27,040,000 | Revenue Growth: | 32.86% |
| Revenue Growth (this year): | 22.41% | Revenue Growth (next year): | 19.97% |
Latest DarioHealth Corp. News
DRIO Breaking Stock News: Dive into DRIO Ticker-Specific Updates for Smart Investing
PR Newswire
4 days ago
Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
PR Newswire
5 days ago
DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025
PR Newswire
11 days ago
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives
PR Newswire
21 days ago
DarioHealth Announces CFO Transition
PR Newswire
25 days ago
DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers
PR Newswire
a month ago
Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion
Zacks
2 months ago
DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know
Business Wire
2 months ago
Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth
Compare DRIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DRIO DarioHealth Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.